Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCardiogenic Shock and Respiratory Failure in a Patient With Metastatic Melanoma Receiving Trametinib Therapy.AuthorsTseng, Diane; Mason, Xenos L.; Neilan, Tomas G.; Sullivan, Ryan J.AbstractLife‐threatening heart failure can occur with trametinib therapy and is reversible. This article provides recommendations for evaluation of patients receiving trametinib, including those who develop severe cardiomyopathy.SubjectsANTINEOPLASTIC agents; CARDIOGENIC shock; HEART failure; MELANOMA; METASTASIS; CARDIOMYOPATHIES; RESPIRATORY insufficiency; RESPIRATORY syncytial virusPublicationOncologist, 2016, Vol 21, Issue 9, p1136ISSN1083-7159Publication typeArticleDOI10.1634/theoncologist.2016-0080